Labopharm Inc.

Details Labopharm Inc. Labopharm Inc.

www.labopharm.com

Quebec

Montreal

Chomedey

Corporation

active

Labopharm is an emerging pharmaceutical company whose goal is to
become a leading supplier of controlled-release systems to the
pharmaceutical industry worldwide. Its core platform technology,
Contramid, applies to a wide range of medications in solid dosage
forms to improve their oral administration and performance.
Contramid is patented and provides a means to add economic value
to existing products or new chemical entities (NCEs), through
extended patent protection and/or better product differentiation.
Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) is an international, specialty pharmaceutical company focused on the development of drugs incorporating Contramid®, the Company€™s proprietary advanced controlled-release technology. In the last years, Labopharm signed mutiple licensing agreements with international pharmaceutical companies to market on the US, Europe - Latin America a pain controlled-release product developed by Labopharm Inc.
Labopharm is located in the greater Montreal area and benefits
from the region's well-established pharmaceutical infrastructure
which provides access to a number of recognized contract
research and contract manufacturing organizations, as required,
as well as a favourable tax environment.
Country of Ownership: Canada
Year Established: 1991
Exporting: Yes
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer
Total Sales ($CDN): $1,000,000 to $4,999,999
Export Sales ($CDN): $1,000,000 to $4,999,999
Number of Employees: 150

Products:
Contramid

Affiliated with

Also associated with

No associations

Rating

Labopharm Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Labopharm Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Labopharm Inc. will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-COD-O-8097